Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Women live longer than men even during severe famines and epidemics.

Zarulli V, Barthold Jones JA, Oksuzyan A, Lindahl-Jacobsen R, Christensen K, Vaupel JW.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E832-E840. doi: 10.1073/pnas.1701535115. Epub 2018 Jan 8.

2.

Countervailing effects of income, air pollution, smoking, and obesity on aging and life expectancy: population-based study of U.S. Counties.

Allen RT, Hales NM, Baccarelli A, Jerrett M, Ezzati M, Dockery DW, Pope CA 3rd.

Environ Health. 2016 Aug 12;15(1):86. doi: 10.1186/s12940-016-0168-2.

3.

Medical costs and quality-adjusted life years associated with smoking: a systematic review.

Feirman SP, Glasser AM, Teplitskaya L, Holtgrave DR, Abrams DB, Niaura RS, Villanti AC.

BMC Public Health. 2016 Jul 27;16:646. doi: 10.1186/s12889-016-3319-z. Review.

4.

Longevity loss among cured tuberculosis patients and the potential value of prevention.

Hoger S, Lykens K, Beavers SF, Katz D, Miller TL.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1347-52. doi: 10.5588/ijtld.14.0242.

5.

COMBINING PREVALENCE AND MORTALITY RISK RATES: THE CASE OF CIGARETTE SMOKING.

Rogers RG, Hummer RA, Krueger PM, Pampel FC.

Popul Dev Rev. 2005 Jun;31(2):259-292.

6.

Contributions of major smoking-related diseases to reduction in life expectancy associated with smoking in Chinese adults: a cross-sectional study.

Han W, Jiang J, Li J, Zeng X, Zou X, Wu Y, Chen Y, Zhao P, Hou L, Pang H, Liu B.

BMC Public Health. 2013 Dec 9;13:1147. doi: 10.1186/1471-2458-13-1147.

7.

Diffusion, cohort change, and social patterns of smoking().

Pampel FC.

Soc Sci Res. 2005 Mar;34(1):117-139.

8.

The cost-effectiveness of a school-based smoking prevention program in India.

Brown HS 3rd, Stigler M, Perry C, Dhavan P, Arora M, Reddy KS.

Health Promot Int. 2013 Jun;28(2):178-86. doi: 10.1093/heapro/dar095. Epub 2012 Jan 23.

9.

Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation.

Javitz HS, Zbikowski SM, Deprey M, McAfee TA, McClure JB, Richards J, Catz SL, Jack LM, Swan GE.

Transl Behav Med. 2011 Mar 1;1(1):182-190.

10.

Differences in health between Americans and Western Europeans: Effects on longevity and public finance.

Michaud PC, Goldman D, Lakdawalla D, Gailey A, Zheng Y.

Soc Sci Med. 2011 Jul;73(2):254-63. doi: 10.1016/j.socscimed.2011.05.027. Epub 2011 Jun 2.

11.

Trends in the genetic influences on smoking.

Boardman JD, Blalock CL, Pampel FC.

J Health Soc Behav. 2010 Mar;51(1):108-23.

12.

Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women.

Ruger JP, Emmons KM, Kearney MH, Weinstein MC.

BMC Pregnancy Childbirth. 2009 Sep 23;9:46. doi: 10.1186/1471-2393-9-46.

13.

Using the National Health Interview Survey to understand and address the impact of tobacco in the United States: past perspectives and future considerations.

Backinger CL, Lawrence D, Swan J, Winn DM, Breen N, Hartman A, Grana R, Tran D, Farrell S.

Epidemiol Perspect Innov. 2008 Dec 4;5:8. doi: 10.1186/1742-5573-5-8.

14.

Reduced life expectancy due to smoking in large-scale cohort studies in Japan.

Ozasa K, Katanoda K, Tamakoshi A, Sato H, Tajima K, Suzuki T, Tsugane S, Sobue T.

J Epidemiol. 2008;18(3):111-8. Epub 2008 May 14.

15.

Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.

Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM.

Value Health. 2008 Mar-Apr;11(2):191-8. Epub 2007 Sep 13.

16.

Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.

Cornuz J, Gilbert A, Pinget C, McDonald P, Slama K, Salto E, Paccaud F.

Tob Control. 2006 Jun;15(3):152-9.

17.

Cost effectiveness of a community based research project to help women quit smoking.

Secker-Walker RH, Holland RR, Lloyd CM, Pelkey D, Flynn BS.

Tob Control. 2005 Feb;14(1):37-42.

18.

The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.

Gilbert AR, Pinget C, Bovet P, Cornuz J, Shamlaye C, Paccaud F.

Tob Control. 2004 Jun;13(2):190-5.

19.

Mortality among male and female smokers in Sweden: a 33 year follow up.

Nilsson S, Carstensen JM, Pershagen G.

J Epidemiol Community Health. 2001 Nov;55(11):825-30.

Supplemental Content

Support Center